Lamivudine in renal transplant candidates with chronic hepatitis B infection.
Boyacioglu
S
S
Baskent University Faculty of Medicine, Ankara, Turkey. melekk@baskent-ank.edu.tr
Gür
G
G
Gürsoy
M
M
Ozdemir
N
N
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012449:Safety
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies; D019259:Lamivudine; D000410:Alanine Transaminase